99% Invisible cover image

Orphan Drugs

99% Invisible

00:00

How Companies Capitalized on Orphan Drug Incentives

Dan Weissmann and Roman Mars describe rising orphan drug prices and the industry's recognition of lucrative opportunities.

Play episode from 16:20
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app